Crossref
Human β-Defensins in Colonic Mucosa of Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Healthy Controls – A Pilot Study
AGLP · 08.04.2026 · 1 (1)
DOI: 10.17303/aglp.2024.1.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift AGLP, online erschienen am 11.08.2026. Verfasst von Ghazaleh Mohammadian.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mohammadian, G. (2026). Human β-Defensins in Colonic Mucosa of Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Healthy Controls – A Pilot Study. AGLP, 1(1). https://doi.org/10.17303/aglp.2024.1.105
Vancouver
Mohammadian G. Human β-Defensins in Colonic Mucosa of Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Healthy Controls – A Pilot Study. AGLP. 2026;1(1). doi:10.17303/aglp.2024.1.105
BibTeX
@article{Mohammadian2026,
author = {Mohammadian, Ghazaleh},
title = {Human β-Defensins in Colonic Mucosa of Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Healthy Controls – A Pilot Study},
journal = {AGLP},
year = {2026},
volume = {1},
number = {1},
doi = {10.17303/aglp.2024.1.105}
}
EUVIMED